Optimum timing of lung resection surgery following SARS‐CoV‐2 infection for non‐small cell lung cancer

Ähnliche Einträge

• Automated CT quantification of interstitial lung abnormality in patients with resectable stage I non‐small cell lung cancer: Prognostic significance
  von: Jae Ho Chung, et al.
  Veröffentlicht: (2024)
• Immune responses and reinfection of SARS‐CoV ‐2 Omicron variant in patients with lung cancer
  von: Chen Chen, et al.
  Veröffentlicht: (2024)
• Durvalumab after chemoradiotherapy for locoregional recurrence of completely resected non–small‐cell lung cancer (NEJ056)
  von: Megumi Furuta, et al.
  Veröffentlicht: (2024)
• Is wedge resection equivalent to segmentectomy in pathological stage IA (≤2 cm) non‐small cell lung cancers?
  von: Zhirong Zhang, et al.
  Veröffentlicht: (2024)
• Comparison of survivals between sublobar resection and lobar resection for patients with clinical stage I non‐small cell lung cancer and interstitial lung disease: a propensity score matching analysis
  von: Ryohei Matsushima, et al.
  Veröffentlicht: (2024)